Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05753722
Title A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Parthenon Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Yale Cancer Center RECRUITING New Haven Connecticut 06511 United States Details
Mass General Cancer Center RECRUITING Boston Massachusetts 02114 United States Details
Providence Cancer Institute Franz Clinic RECRUITING Portland Oregon 97213 United States Details
University of Pittsburgh Medical Center Hillman Cancer Center RECRUITING Pittsburgh Pennsylvania 15232 United States Details
Vanderbilt-Ingram Cancer Center RECRUITING Nashville Tennessee 27232 United States Details
The University of Texas MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Next Oncology RECRUITING Irving Texas 75039 United States Details
NEXT Oncology RECRUITING San Antonio Texas 78229 United States Details
Next Oncology RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field